NAYA Biosciences Common Stock OverviewNAYA Biosciences Common Stock Cost of Revenue
Cost of Revenue analysis for IVF.
Quarterly Cost of Revenue
$3.24M
↓ 99.91% YoY
As of Dec 31, 2025
Annual Cost of Revenue (TTM)
$3.27B
↓ 10.61% YoY
Trailing 12 months ending Dec 31, 2025